---
id: erysipelothrix-whipple_330
category: organisms
tags: [Erysipelothrix-rhusiopathiae, erysipeloid, Whipple-disease, Tropheryma-whipplei, fish-handler, PAS-positive, TMP-SMX]
deck: Infectious Diseases
created: 2025-01-11
modified: 2025-01-11
---

## Erysipelothrix rhusiopathiae and Whipple Disease

**Q:** What are the clinical presentations and treatments for erysipeloid and Whipple disease?

**A:**

**Erysipelothrix rhusiopathiae:**

**Overview:**
- Gram-positive rod
- **Occupational infection**: Fish/meat handlers, farmers, veterinarians

**Clinical Syndromes:**

**1. Erysipeloid (Localized Cutaneous - Most Common):**
- **Violaceous, well-demarcated** painful plaque on fingers/hands
- **Burning, itching** sensation
- Develops ~**10 days post-inoculation** (fish/meat handling)
- Self-limited (3-4 weeks)

**2. Diffuse Cutaneous:**
- Spreading lesions beyond initial site

**3. Septicemia:**
- **Endocarditis** (almost always accompanies bacteremia)
- **Native valve** (more common than prosthetic)

**Treatment:**
- **Uncomplicated**: **Penicillin 500 mg PO q6h × 7 days** OR amoxicillin
- **Severe/endocarditis**: **Penicillin G IV** or ampicillin
- Alternatives: Cephalosporins, fluoroquinolones, clindamycin
- **RESISTANT to vancomycin** (important for empiric endocarditis coverage)

---

**Whipple Disease (Tropheryma whipplei):**

**Overview:**
- Gram-positive actinomycete (rare, chronic systemic infection)
- Middle-aged Caucasian men (>90%)

**Clinical Presentation (Classic Triad + CNS):**
1. **Diarrhea** (chronic, malabsorptive with steatorrhea)
2. **Weight loss**
3. **Arthralgias/arthritis** (often **precedes GI symptoms by years**)
4. **CNS involvement** (10-40%): Dementia, ophthalmoplegia, myoclonus, seizures

**Other features:**
- Hyperpigmentation, lymphadenopathy
- Cardiac: Endocarditis, pericarditis
- **Fever** common

**Diagnosis:**
- **Duodenal biopsy**: **PAS-positive macrophages** (foamy, packed with bacteria)
- PCR (blood, CSF, tissue)
- Histology: Dilated lacteals, villous blunting

**Treatment:**

**Induction (2-4 weeks):**
- **Ceftriaxone 2 g IV daily × 2-4 weeks** OR meropenem 1 g IV daily × 2 weeks

**Maintenance (1 year):**
- **TMP-SMX 160/800 mg PO BID × 1 year** (NOTE: Only **sulfamethoxazole active**; TMP inactive against T. whipplei)

**Alternative:**
- **Doxycycline 100 mg PO BID + hydroxychloroquine 200 mg PO TID × 1 year**

**CNS Whipple:**
- Requires **prolonged treatment** (≥1 year)
- Must use **CNS-penetrating agents** (ceftriaxone, TMP-SMX)

**Key Points:**
- **Erysipeloid**: Fish handler's disease; violaceous finger/hand plaque; penicillin × 7 days; **vancomycin-resistant**
- **Whipple**: Diarrhea + weight loss + arthralgias; **PAS-positive** macrophages; ceftriaxone induction → TMP-SMX × 1 year

**Mnemonic - "Whipple = Weight loss, Hyperpigmentation, Intestinal malabsorption, PAS-positive, Prolonged treatment, Lone white males, Encephalopathy"**

**Pearl:** Erysipelothrix is vancomycin-resistant (important for empiric endocarditis therapy). Whipple disease requires 2-4 weeks IV ceftriaxone THEN TMP-SMX × 1 year (only the sulfa component is active). PAS-positive macrophages on duodenal biopsy are diagnostic.

**Media:**

**Sources:** [Merck Manual Erysipeloid], [PMC5355640 - T. whipplei Clinical Manifestations], [Antimicrobe.org Whipple Disease], [PMC12169642 - Whipple CNS Involvement 2024]
